Epigenetic profiles distinguish pleural mesothelioma from normal pleura and predict lung asbestos burden and clinical outcome

Cancer Research

Volumn 69, Issue 1, 2009, Pages 227-234

  Christensen, Brock C ^a,b   Houseman, E A ^a,c,d   Godleski, John J ^d   Marsit, Carmen J ^b   Longacker, Jennifer L ^e   Roelofs, Cora R ^c   Karagas, Margaret R ^g   Wrensch, Margaret R ^h   Yeh, Ru Fang ^h   Nelson, Heather H ⁱ   Wiemels, Joe L ^h   Zheng, Shichun ^h   Wiencke, John K ^h   Bueno, Raphael ^f   Sugarbaker, David J ^f   Kelsey, Karl T ^a,b  

^a BROWN UNIVERSITY   (United States)

^b BROWN UNIVERSITY   (United States)

^c UNIVERSITY OF MASSACHUSETTS LOWELL   (United States)

^d HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^e BOSTON UNIVERSITY SCHOOL OF PUBLIC HEALTH   (United States)

^f BRIGHAM AND WOMEN S HOSPITAL   (United States)

^g DARTMOUTH MEDICAL SCHOOL   (United States)

^h UNIVERSITY OF CALIFORNIA   (United States)

ⁱ UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; ASBESTOSIS; CANCER SURVIVAL; CPG ISLAND; DNA FINGERPRINTING; DNA METHYLATION; DRUG MECHANISM; EPIGENETICS; FEMALE; GENE; GENE LOCUS; GENETIC EPIGENESIS; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MATHEMATICAL MODEL; MIXTURE MODEL APPROACH; MT1A GENE; MT2A GENE; ONCOGENE; PHENOTYPE; PLEURA MESOTHELIOMA; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; RANDOM FORESTS CLASSIFICATION; STATISTICAL MODEL; SURVIVAL RATE;

ADULT; AGED; AGED, 80 AND OVER; ASBESTOS; CPG ISLANDS; DNA METHYLATION; EPIGENESIS, GENETIC; FEMALE; HUMANS; LUNG; MALE; MESOTHELIOMA; MIDDLE AGED; PLEURA; PLEURAL NEOPLASMS;

EID: 58249128191     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-08-2586     Document Type: Article

References (49)

1. Fearon ER, Vogelstein B. A genetic model for colorectal tumorigenesis. Cell 1990;61:759-67.
2. Loeb LA. Mutator phenotype may be required for multistage carcinogenesis. Cancer Res 1991;51:3075-9.
3. Jones PA, Baylin SB. The fundamental role of epigenetic events in cancer. Nat Rev 2002;3:415-28.
4. Bibikova M, Lin Z, Zhou L, et al. High-throughput DNA methylation profiling using universal bead arrays. Genome Res 2006;16:383-93.
5. Robinson BW, Lake RA. Advances in malignant mesothelioma. N Engl J Med 2005;353:1591-603.
6. Morinaga K, Kishimoto T, Sakatani M, Akira M, Yokoyama K, Sera Y. Asbestos-related lung cancer and mesothelioma in Japan. Ind Health 2001;39:65-74.
7. Price B, Ware A. Mesothelioma trends in the United States: an update based on Surveillance, Epidemiology, and End Results Program data for 1973 through 2003. Am J Epidemiol 2004;159:107-12.
8. Roushdy-Hammady I, Siegel J, Emri S, Testa JR, Carbone M. Genetic-susceptibility factor and malignant mesothelioma in the Cappadocian region of Turkey. Lancet 2001;357:444-5.
9. Bhagavatula R, Moody R, Russ J. Asbestos: a moving target. Best's Rev 2001;102:85-90.
10. Peto J, Decarli A, La Vecchia C, Levi F, Negri E. The European mesothelioma epidemic. Br J Cancer 1999;79:666-72.
11. Joshi TK, Gupta RK. Asbestos in developing countries: magnitude of risk and its practical implications. Int J Occup Med Environ Health 2004;17:179-85.
12. Landrigan PJ, Lioy PJ, Thurston G, et al. Health and environmental consequences of the world trade center disaster. Environ Health Perspect 2004;112:731-9.
13. Wagner JC, Sleggs CA, Marchand P. Diffuse pleural mesothelioma and asbestos exposure in the North Western Cape Province. Br J Ind Med 1960;17:260-71.
14. Jaurand MC. Mechanisms of fiber-induced genotoxicity. Environ Health Perspect 1997;105 Suppl 5:1073-84.
15. Kelsey KT, Yano E, Liber HL, Little JB. The in vitro genetic effects of fibrous erionite and crocidolite asbestos. Br J Cancer 1986;54:107-14.
16. He B, Lee AY, Dadfarmay S, et al. Secreted frizzled-related protein 4 is silenced by hypermethylation and induces apoptosis in h-catenin-deficient human mesothelioma cells. Cancer Res 2005;65:743-8.
17. Hirao T, Bueno R, Chen CJ, Gordon GJ, Heilig E, Kelsey KT. Alterations of the p16(INK4) locus in human malignant mesothelial tumors. Carcinogenesis 2002;23:1127-30.
18. Tsou JA, Galler JS, Wali A, et al. DNA methylation profile of 28 potential marker loci in malignant mesothelioma. Lung Cancer 2007;58:220-30.
19. Tsou JA, Shen LY, Siegmund KD, et al. Distinct DNA methylation profiles in malignant mesothelioma, lung adenocarcinoma, and non-tumor lung. Lung Cancer 2005;47:193-204.
20. Christensen BC, Godleski JJ, Marsit CJ, et al. Asbestos exposure predicts cell cycle control gene promoter methylation in pleural mesothelioma. Carcinogenesis 2008;29:1555-9.
21. De Vuyst P, Karjalainen A, Dumortier P, et al. 1998 ERS Task Force Report Guidelines for mineral fibre analyses in biological samples: report of the ERS working group. Eur Respir J 1998;11:1416-26.
22. Churg A, Warnock ML. Correlation of quantitative asbestos body counts and occupation in urban patients. Arch Pathol Lab Med 1977;101:629-34.
23. R Development CT. R: A Language and Environment for Statistical Computing. Vienna (Austria): R Foundation for Statistical Computing; 2007.
24. Hsiung DT, Marsit CJ, Houseman EA, et al. Global DNA methylation level in whole blood as a biomarker in head and neck squamous cell carcinoma. Cancer Epidemiol Biomarkers Prev 2007;16:108-14.
25. Storey J, Taylor J, Siegmund D. Strong control, conservative point estimation, and simultaneous conservative consistency of false discovery rates: A unified approach. J Royal Stat Soc 2004;Series B:187-205.
26. Houseman EA, Christensen BC, Marsit CJ, et al. Model-based clustering of DNA methylation array data: a recursive-partitioning algorithm for high-dimensional data arising as a mixture of β distributions. BMC Bioinformatics 2008;9.
27. Yao Y. Information-theoretic measures for knowledge discovery and data mining In: Karmeshu, editor. Entropy Measures, Maximum Entropy Principle and Emerging Applications: Springer; 2003. p. 115-36.
28. Breiman L. Random Forests. Machine Learning 2001;45:5-32.
29. Shen L, Toyota M, Kondo Y, et al. Integrated genetic and epigenetic analysis identifies three different subclasses of colon cancer. Proc Natl Acad Sci U S A 2007;104:18654-9.
30. Siegmund KD, Connor CM, Campan M, et al. DNA methylation in the human cerebral cortex is dynamically regulated throughout the life span and involves differentiated neurons. PLoS ONE 2007;2:e895.
31. Siegmund KD, Laird PW, Laird-Offringa IA. A comparison of cluster analysis methods using DNA methylation data. Bioinformatics (Oxford England) 2004;20:1896-904.
32. Christensen BC, Godleski JJ, Roelofs CR, et al. Asbestos burden predicts survival in pleural mesothelioma. Environ Health Perspect 2008;116:723-6.
33. Sugarbaker DJ, Richards WG, Gordon GJ, et al. Transcriptome sequencing of malignant pleural mesothelioma tumors. Proc Natl Acad Sci U S A 2008;105:3521-6.
34. Gordon GJ, Rockwell GN, Jensen RV, et al. Identification of novel candidate oncogenes and tumor suppressors in malignant pleural mesothelioma using large-scale transcriptional profiling. Am J Pathol 2005;166:1827-40.
35. Gordon GJ, Jensen RV, Hsiao LL, et al. Using gene expression ratios to predict outcome among patients with mesothelioma. J Natl Cancer Inst 2003;95:598-605.
36. Gordon GJ, Rockwell GN, Godfrey PA, et al. Validation of genomics-based prognostic tests in malignant pleural mesothelioma. Clin Cancer Res 2005;11:4406-14.
37. Lopez-Rios F, Chuai S, Flores R, et al. Global gene expression profiling of pleural mesotheliomas: overexpression of aurora kinases and P16/CDKN2A deletion as prognostic factors and critical evaluation of microarray-based prognostic prediction. Cancer Res 2006;66:2970-9.
38. Moalli PA, MacDonald JL, Goodglick LA, Kane AB. Acute injury and regeneration of the mesothelium in response to asbestos fibers. Am J Pathol 1987;128:426-45.
39. Issa JP, Ahuja N, Toyota M, Bronner MP, Brentnall TA. Accelerated age-related CpG island methylation in ulcerative colitis. Cancer Res 2001;61:3573-7.
40. Quinlan TR, Marsh JP, Janssen YM, Borm PA, Mossman BT. Oxygen radicals and asbestos-mediated disease. Environ Health Perspect 1994;102 Suppl 10:107-10.
41. Chen Q, Marsh J, Ames B, Mossman B. Detection of 8-oxo-2′- deoxyguanosine, a marker of oxidative DNA damage, in culture medium from human mesothelial cells exposed to crocidolite asbestos. Carcinogenesis 1996;17:2525-7.
42. Masuda T, Shinoara H, Kondo M. Reactions of hydroxyl radicals with nucleic acid bases and the related compounds in γ-irradiated aqueous solution. J Radiat Res 1975;16:153-61.
43. Valinluck V, Tsai HH, Rogstad DK, Burdzy A, Bird A, Sowers LC. Oxidative damage to methyl-CpG sequences inhibits the binding of the methyl-CpG binding domain (MBD) of methyl-CpG binding protein 2 (MeCP2). Nucleic Acids Res 2004;32:4100-8.
44. Valinluck V, Sowers LC. Endogenous cytosine damage products alter the site selectivity of human DNA maintenance methyltransferase DNMT1. Cancer Res 2007;67:946-50.
45. Henderson JP, Byun J, Takeshita J, Heinecke JW. Phagocytes produce 5-chlorouracil and 5-bromouracil, two mutagenic products of myeloperoxidase, in human inflammatory tissue. J Biol Chem 2003;278:23522-8.
46. Hanahan D, Weinberg RA. The hallmarks of cancer. Cell 2000;100:57-70.
47. Li JY, Chai BX, Zhang W, Liu YQ, Ammori JB, Mulholland MW. Ankyrin repeat and SOCS box containing protein 4 (Asb-4) interacts with GPS1 (CSN1) and inhibits c-Jun NH2-terminal kinase activity. Cell Signal 2007;19:1185-92.
48. Yoshimura A, Naka T, Kubo M. SOCS proteins, cytokine signalling and immune regulation. Nat Rev Immunol 2007;7:454-65.
49. Trivedi CM, Patel RC, Patel CV. Homeobox gene HOXA9 inhibits nuclear factor-κ B dependent activation of endothelium. Atherosclerosis 2007;195:e50-60.